News

Abbott announced that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacement…
Read More...

Silence Therapeutics announces that its lead medicine candidate SLN124 has been granted Orphan Drug Designation by the Committee for Orphan Medicinal Products (COMP), the European…
Read More...

Cobra Biologics announced the appointment of Dr Darrell Sleep as Director of Innovation. The appointment is part of on-going strategic expansion activities currently underway at Cobra’s…
Read More...

Exelixis announced that the U.S. Food and Drug Administration (FDA) approved CABOMETYX (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously…
Read More...

Puma Biotechnology announced that it has entered into an exclusive License Agreement with Knight Therapeutics Inc. that grants Knight the exclusive right to commercialize NERLYNX…
Read More...

SAMDI Tech, Inc., the industry’s leading provider of label-free drug discovery solutions, has promoted Michael D. Scholle to chief operating officer. Formerly serving as director and…
Read More...

SIRION Biotech GmbH announced that it signed a license and collaboration agreement with Denali Therapeutics, a biopharmaceutical company developing a broad portfolio of product…
Read More...

Clinigen Group plc announces that its Clinical Trial Service business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also…
Read More...

Selexis SA announced that it has signed additional commercial license agreements (CLAs) with Agenus, an immuno-oncology company with a pipeline of immune-modulating antibodies, cancer…
Read More...

Takeda Pharmaceutical Company Limited announced the completion of its acquisition of Shire plc, becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in…
Read More...

AbSci announced a collaboration with Sanofi.  Under the terms of the agreement, AbSci will apply its breakthrough E.coli manufacturing platform, SoluProTM, and its novel optimization…
Read More...

Pharmaceutics International announced its partner, Academic Pharmaceuticals, Inc., received FDA approval of Bretylium Tosylate Injection USP, 500 mg/10 mL (50 mg/mL) Single-Dose Vials…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has granted crizanlizumab (SEG101) Breakthrough Therapy designation for the prevention of vaso-occlusive crises (VOCs)…
Read More...

Almac Sciences, a member of the Almac Group, has expanded its technology capabilities within its Active Pharmaceutical Ingredients (API) services & chemical development portfolio…
Read More...

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases announced its plans to initiate a…
Read More...

Aphena Pharma Solutions Inc. has announced the expansion of its blister packaging capacity with the purchase of a PharmaWorks TF2 blister packaging line with in-line cartoning…
Read More...

Ascentage Pharma announced that Unity Biotechnology has selected one of Ascentage's compounds as its lead development candidate in its ophthalmology pipeline to advance into further…
Read More...

Generex Biotechnology Corporation announced that the company has completed the acquisition of 51% of Olaregen Therapeutix Inc., a New York based regenerative medicine company that is…
Read More...

CANbridge Pharmaceuticals and WuXi Biologics jointly announced an expansion of their rare disease partnership to enable CANbridge to discover, develop and commercialize four additional…
Read More...

Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, announced that it has entered into a collaboration agreement with BioMed X Innovation…
Read More...